Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation
{{output}}
The noradrenergic locus ceruleus (LC) is the first site of detectable tau pathology in Alzheimer's disease (AD), but the mechanisms underlying the selective vulnerability of the LC in AD have not been completely identified. In the present study, we show that D... ...
